| | | | | | | | | | |
|
|
| Dockets Entered
On February 21, 2007
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| 2003N-0400
|
| Control of Communicable Diseases; Restrictions on African Rodents, Prairie Dogs, and Certain Other Animals
|
|
|
| 2005N-0394
|
| FDAs Communication of Drug Safety Information; Public Hearing
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2007M-0058
|
| P050007/S001 - StarClose Vascular Closure System, Model 1004, Version 2.10
|
|
|
| 2007N-0005
|
| Prescription Drug User Fee Act (PDUFA): Public Meeting
|
|
|
| 1997S-0162
|
| 30-Day Structure Function Claim Notification Letters Dietary
|
|
|
| LET 18731
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 169
|
|
|
| LET 18732
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 169
|
|
|
| LET 18733
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 169
|
|
|
| LET 18734
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 169
|
|
|
| LET 18735
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 169
|
|
|
| LET 18736
|
| NBTY Inc.
|
| Vol #:
|
| 169
|
|
|
| LET 18737
|
| NBTY Inc.
|
| Vol #:
|
| 169
|
|
|
| LET 18738
|
| NBTY Inc.
|
| Vol #:
|
| 169
|
|
|
| LET 18739
|
| NBTY Inc.
|
| Vol #:
|
| 169
|
|
|
| LET 18740
|
| NBTY Inc.
|
| Vol #:
|
| 169
|
|
|
| LET 18741
|
| NBTY Inc.
|
| Vol #:
|
| 169
|
|
|
| LET 18742
|
| NBTY Inc.
|
| Vol #:
|
| 169
|
|
|
| LET 18743
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 169
|
|
|
| LET 18744
|
| Perrigo Company of South Carolina
|
| Vol #:
|
| 169
|
|
|
| LET 18745
|
| Arthur Andrew Medicals, Inc.
|
| Vol #:
|
| 170
|
|
|
| LET 18746
|
| Traditional Medicinals, Inc.
|
| Vol #:
|
| 170
|
|
|
| LET 18747
|
| Traditional Medicinals, Inc.
|
| Vol #:
|
| 170
|
|
|
| LET 18748
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18749
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18750
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18751
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18752
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18753
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18754
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18755
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18756
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18757
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
|
| LET 18758
|
| PuraPharm Corporation
|
| Vol #:
|
| 170
|
|
| | | | | | | | |
|
|
| AAV 1
|
| Abbott Vascular Devices
|
| Vol #:
|
| 1
|
|
|
| 2007N-0005
|
| Prescription Drug User Fee Act (PDUFA): Public Meeting
|
|
|
| TS 1
|
| Prescription Drug User Fee Act (PDUFA IV)
|
| Vol #:
|
| 1
|
|
|
| TS 2
|
| FDA - User-Fee Funding of Human Drug Review
|
| Vol #:
|
| 1
|
|
|
| TS 3
|
| K Witczak
|
| Vol #:
|
| 1
|
|
|
| TS 4
|
| Consumers Union
|
| Vol #:
|
| 1
|
|
|
| TS 5
|
| Plasma Protein Therapeutics Association (PPTA)
|
| Vol #:
|
| 1
|
|
|
| TS 6
|
| U S Chamber of Commerce
|
| Vol #:
|
| 1
|
|
|
| TS 7
|
| Committee of Ten Thousand
|
| Vol #:
|
| 1
|
|
|
| TS 8
|
| AHRP
|
| Vol #:
|
| 1
|
|
|
| TS 9
|
| Coalition for Healthcare Communication
|
| Vol #:
|
| 1
|
|
|
| TS 10
|
| Biotechnology Industry Organization
|
| Vol #:
|
| 1
|
|
|
| TS 11
|
| Academy of Managed Care Pharmacy
|
| Vol #:
|
| 1
|
|
|
| TS 12
|
| Drug Safety Institute
|
| Vol #:
|
| 1
|
|
|
| TS 13
|
| Biotechnology Industry Organization
|
| Vol #:
|
| 1
|
|
|
| TS 14
|
| National Research Center for Women & Families
|
| Vol #:
|
| 1
|
|
|
| TS 15
|
| American Society of Health-Systems Pharmacists
|
| Vol #:
|
| 1
|
|
|
| TS 16
|
| Mental Health America
|
| Vol #:
|
| 1
|
|
|
| TS 17
|
| Council on Radionuclides and Radiopharmaceuticals (CORAR)
|
| Vol #:
|
| 1
|
|
|
| TS 18
|
| W DeCamp
|
| Vol #:
|
| 1
|
|